"THANK YOU FOR CARING ABOUT YOUR PATIENTS." - D.G.
We've successfully treated thousands of patients from New Orleans and across the nation. At THE RETINA INSTITUTE you will enjoy premier retinal eye care from only Dr. Ebrahim at one central location, where you will benefit from personalized care, superior technology, and an amazingly attentive staff.
THE RETINA INSTITUTE is the premier New Orleans medical and micro-surgical center for retinal eye disorders including diabetic retinopathy, macular edema, hypertensive retinopathy, macular degeneration, retinal vein occlusions, macular holes, epiretinal membranes (macular pucker or cellophane maculopathy), and retinal detachments.
EXPLORE OUR EYE VIDEO COLLECTION
EXPLORE YOUR PATIENT RESOURCES
DIRECTIONS & HOURS
THE LATEST RETINAL EYE CARE NEWS:
Genetic therapy may allow a Retinitis Pigmentosa patient's own skin cells to be genetically corrected and then used to heal that patient's retina.
Squalamine, derived from sharks, is being tested as a treatment for macular degeneration. It has been shown to be helpful in retinal vein occlusion and may become useful in diabetic retinopathy.
From Alzheimer's to ALS to Multiple Sclerosis to Parkinson's Disease, preliminary studies indicate retinal findings may contribute to diagnosis and staging. The retina is brain tissue and a growing window to brain disorders.
MDM2 inhibitors are under study as a potential new treatment for wet macular degeneration that eliminate the need for repeat injections (click to read more).
Aspirin use as it relates to the eye is complex: it may increase risk in typical macular degeneration, benefit visual outcomes in other retinal disease, and has been shown not to affect diabetic hemorrhages.
HIV medicines may be effective against macular degeneration.
Our high density macular microperimetry and highly sensitive electroretinography technologies are capable of detecting subclinical retinal decline before major vision loss to allow prevention.
Our low duty cycle yellow micropulse laser technology allows the benefits of early treatment in a manner safer than traditional laser.
Targeted genetic therapy shows promising preliminary human trials in reversing choroideremia, a macular degeneration type disorder.
PDGFR-beta antibody (an inhibitor of Platelet Derived Growth Factor beta) has long been on the radar as a potential treatment for wet macular degeneration. Now the maker of Eylea has teamed with Bayer in an attempt to bring an Eylea/PDGFR-beta combination to market. Stay tuned for updates. If successful, the benefit may extend beyond macular degeneration to diabetics and vein occlusion patients as well as others.
Derived from early stem cell research, new treatments may introduce regenerative factors to rejuvenate currently ailing retinal cells without requiring true stem cell transplantation.
There is good reason to be patient for the perfection of true stem cell applications (click to proceed to the link).
The first retinal prosthesis to gain FDA approval is the ARGUS II Retinal Prosthesis System. Though currently it has limited uses, it brings great hope to those with severe retinal disease.
Eylea (aflibercept) has now been approved for use in diabetics. It has been very successful for macular degeneration and retinal vein occlusions.
Concerned about your genetic risk for macular degeneration? Testing is available at THE RETINA INSTITUTE.
For diabetics, regular follow up and treatment by retinal eye doctors are proven to save vision. Conversely, lack of examination can lead to unnecessary vision loss.
High blood pressure (Hypertension) can cause serious vision loss: baseline blood pressure as well as spiking blood pressures from stress or sleep apnea can contribute to vision loss.
Floaters and flashes can signal retinal detachments.
Blurry vision can be much more than a need for glasses. A retinal exam can rule out or treat true eye disease.
THE RETINA INSTITUTE tracks the latest retinal eye research and you can too:
Learn something new on our Facebook & Google+ pages:
FOLLOW OUR EVENTS
CLICK HERE TO USE THE AMSLER GRID
Although the Amsler Grid is the best way to monitor your macular health at home, because most retinal disorders are time sensitive, this test is not a substitute for formal follow up and examination.
UNDERSTAND RETINAL EYE DISORDERS
DIABETIC EYE DISEASE
RETINAL VEIN OCCLUSIONS
THE RETINA INSTITUTE accepts referrals by appointment from Doctors both local and distant.
Many retinal disorders are a manifestation of uncontrolled full body disorders. And much of this is preventable with good primary care. If you are in need of a primary care physician to address your chronic or urgent medical needs, visit our neighbor LA PRIMARY CARE at www.LAPCNOLA.com.
SEE WHAT OUR PATIENTS SAY AND LEAVE US YOUR FEEDBACK